Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug 12:13:952509.
doi: 10.3389/fimmu.2022.952509. eCollection 2022.

M2 Macrophages promote IL-33 expression, ILC2 expansion and mucous metaplasia in response to early life rhinovirus infections

Mingyuan Han  1 , Haley A Breckenridge  1 , Shiuhyang Kuo  1 , Shilpi Singh  1 , Adam G Goldsmith  1 , Yiran Li  1 , Jordan E Kreger  1 , J Kelley Bentley  1 , Marc B Hershenson  1   2
Affiliations

M2 Macrophages promote IL-33 expression, ILC2 expansion and mucous metaplasia in response to early life rhinovirus infections

Mingyuan Han et al. Front Immunol. .

Abstract

Wheezing-associated rhinovirus (RV) infections are associated with asthma development. We have shown that infection of immature mice with RV induces type 2 cytokine production and mucous metaplasia which is dependent on IL-33 and type 2 innate lymphoid cells (ILC2s) and intensified by a second heterologous RV infection. We hypothesize that M2a macrophages are required for the exaggerated inflammation and mucous metaplasia in response to heterologous RV infection. Wild-type C57Bl/6J mice and LysMCre IL4Rα KO mice lacking M2a macrophages were treated as follows: (1) sham infection on day 6 of life plus sham on day 13 of life, (2) RV-A1B on day 6 plus sham on day 13, (3) sham on day 6 and RV-A2 on day 13, or (4) RV-A1B on day 6 and RV-A2 on day 13. Lungs were harvested one or seven days after the second infection. Wild-type mice infected with RV-A1B at day 6 showed an increased number of Arg1- and Retnla-expressing lung macrophages, indicative of M2a polarization. Compared to wild-type mice infected with RV on day 6 and 13 of life, the lungs of LysMCre IL4Rα KO mice undergoing heterologous RV infection showed decreased protein abundance of the epithelial-derived innate cytokines IL-33, IL-25 and TSLP, decreased ILC2s, decreased mRNA expression of IL-13 and IL-5, and decreased PAS staining. Finally, mRNA analysis and immunofluorescence microscopy of double-infected LysMCre IL4Rα KO mice showed reduced airway epithelial cell IL-33 expression, and treatment with IL-33 restored the exaggerated muco-inflammatory phenotype.

Conclusion: Early-life RV infection alters the macrophage response to subsequent heterologous infection, permitting enhanced IL-33 expression, ILC2 expansion and intensified airway inflammation and mucous metaplasia.

Keywords: IL-33; ILC2; M2 macrophage; Rhinovirus; neonate.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Differential expansion of F4/80+CD11c+arginase-1+ M2a-polarized macrophages in wild-type immature mice following heterologous RV infection. Six-day old wild-type mice were inoculated with sham or RV-A1B on day 6 of life and sham or RV-A2 on day 13 of life. (A) On day 14, lungs were harvested, digested with liberase TM, collagenase XI, hyaluronidase 1a, and DNase I, and stained with anti-F4/80, anti-CD11c, anti-arginase-1, and PacBlue (for dead cells). Cells were washed, fixed, and processed for flow cytometry. The panel shows flow cytometry analysis of live F4/80+ CD11c+ arginase-1+ macrophages from the four groups. FMO controls for F4/80, CD11c and arginase are also shown. Data shown are mean ± SD; n=6 per group from two different experiments; *different from sham + sham, P < 0.05 by one-way ANOVA; †different from RV-A1B + sham, P < 0.05 by one-way ANOVA. (B) Lungs were collected on day 14 of life (1 day post RV-A2 or sham infection) from wild-type immature mice inoculated with sham or RV-A1B on day 6 of life and sham or RV-A2 on day 13 of life. Cell suspensions were sorted for CD45+ F4/80+ macrophages. The cell pellet was collected for mRNA expression by quantitative PCR (N=6/group, lungs from two mice were combined for each measurement). Data shown are mean ± SD; *different from sham+sham, P < 0.05 by one-way ANOVA; †different from RV-A1B+sham, P < 0.05 by one-way ANOVA.
Figure 2
Figure 2
LysMCre IL-4Rα KO attenuates heterologous RV infection-induced type 2 cytokine expression. Six-day old immature wild-type and LysMCre IL-4Rα KO mice were inoculated with sham or RV-A1B on day 6 and sham or RV-A2 on day 13 of life. (A) mRNA and protein expression of the type 2 cytokines IL-5 and IL-13. Lungs were harvested for qPCR or ELISA seven days after secondary sham or RV-A2 infection. (N =6 from two different experiments, mean ± SD; *different from wildtype sham + RV-A1B, P < 0.05 by one-way ANOVA; †different from wild-type RV-A1B + RV-A2, P < 0.05 by one-way ANOVA.) (B) mRNA and protein expression of the pro-inflammatory cytokines IL-1β, TNF-α, CXCL-1, and IFN-γ. Lungs were harvested for qPCR or ELISA one day after secondary sham or RV-A2 infection. (N =6 from two different experiments, mean ± SD; *different from wild-type sham + RV-A2, P < 0.05 by one-way ANOVA; †different from wild-type RV-A1B + RV-A2, P < 0.05 by one-way ANOVA. (C) Whole lung RV positive-strand RNA one day after secondary infection with sham or RV-A2. (N=6 from two different experiments, mean ± SD; different from sham + RV-A2, P < 0.05 by one-way ANOVA.
Figure 3
Figure 3
LysMCre IL-4Rα KO attenuated heterologous RV infection-enhanced innate cytokine expression. (A, B) Six-day old immature wild-type and LysMCre IL-4Rα KO mice were inoculated with sham or RV-A1B on day 6 and sham or RV-A2 on day 13 of life. Lungs were harvested for qPCR (A) or ELISA (B) one day post sham or RV-A2 secondary infection for IL-33 and seven days after sham or RV-A2 infection for IL-25 and TSLP expression. (N=6-10 from two different experiments, mean ± SD; *different from RV-A1B + sham (IL-25 and TSLP) or wild-type sham + RV-A2 (IL-33), P < 0.05 by one-way ANOVA; †different from wild-type RV-A1B+RV-A2, P < 0.05 by one-way ANOVA.
Figure 4
Figure 4
LysMCre IL-4Rα KO blocks lung ILC2 expansion in 6-day old mice following heterologous RV infection. Wild-type and LysMCre IL-4Rα KO mice were inoculated with sham or RV-A1B on day 6 of life and sham or RV-A2 on day 13 of life. On day 20, lungs were harvested, digested with liberase TM, collagenase XI, hyaluronidase 1a, and DNase I, and stained with lineage antibody cocktail, anti-CD127, anti-ST2 and Pacific blue (for dead cells). Cells were washed, fixed, and processed for flow cytometry. (A) Figure showing flow cytometry analysis of live lineage-negative, CD127+ ST2+ ILC2s from sham + sham, RV-A1B + sham, sham + RV-A2 and RV-A1B + RV-A2 groups. (B) Graph showing group mean data for ILC2s as a percentage of lineage-negative cells (left panel), as a percentage of live lung cells (middle panel) and as a total ILC2s number per lung (right panel) (N=6 from two different experiments, mean± SD; *different from wild-type RV-A1B+sham, P < 0.05 by one-way ANOVA; †different from wild-type RV-A1B + sham or RV-A1B + RV-A2, P < 0.05 by one-way ANOVA.
Figure 5
Figure 5
LysMCre IL-4Rα KO attenuated heterologous RV infection-exaggerated mucus metaplasia and type 2 immune responses. Six-day old immature wild-type and LysMCre IL-4Rα KO mice were inoculated with sham or RV-A1B on day 6 and sham or RV-A2 on day 13 of life. Lungs were harvested on seven days after the secondary infection (sham or RV-A2) and processed for qPCR and histology. Lungs sections were stained for PAS and quantified using NIH ImageJ. (A) mRNA expression of Muc5ac, and Gob5 (Clca1) in sham + sham, sham + RV-A1B, sham + RV-A2, and RV-A1B + RV-A2-infected mice. (N =6 from two different experiments, mean± SD; *different from wild-type RV-A1B + sham, P < 0.05 by one-way ANOVA; †different from wild-type RV-A1B + sham or RV-A1B + RV-A2, P < 0.05 by one-way ANOVA. (B) PAS staining in sham, RV-A1B, RV-A2, RV-A1B+RV-A2-infected wild-type and LysMCre IL-4Rα KO mice. The black bar is 50 microns (μ). (C) Quantification of PAS staining in the airways. Data are represented are PAS-positive cells per micron of basement membrane length. Data shown are mean ± SD; n=2-3 airways/mouse, 6 mice per group from two different experiments; *different from wild-type RV-A1B + sham, P < 0.05 by one-way ANOVA; †different from wild-type RV-A1B + RV-A2, P < 0.05 by one-way ANOVA.
Figure 6
Figure 6
Recombinant IL-33 restores type 2 immune responses and mucus metaplasia in LysMCre IL-4Rα KO mice with heterologous RV infection. Six-day old immature LysMCre IL-4Rα KO mice were inoculated with either sham on day 6 and 13 or RV-A1B on day 6 and RV-A2 on day 13 of life. Selected LysMCre IL-4Rα KO mice were also treated with 0.1 µg of mouse recombinant IL-33 intranasally on day 13 of life. Lungs were harvested on day 20 (7 days post secondary sham or RV-A2 infection) and processed for qPCR (A) and histology (C). (A) mRNA expression of IL-5, IL-13, IL-25, Muc5ac, and Gob5 (Clca1); N =6 from two different experiments, mean± SD; *different from LysMCre IL-4Rα KO sham + sham, P < 0.05 by one-way ANOVA; †different from LysMCre IL-4Rα KO RV-A1B+RV-A2, P < 0.05 by one-way ANOVA. (B) PAS staining in LysMCre IL-4Rα KO mice. The black bar is 50 microns. (C) Quantification of PAS staining in the airways. Data are represented are PAS-positive cells per micron of basement membrane length. Data shown are mean ± SD; n=2-3 airways/mouse, 6 mice per group from two different experiments; *different from LysMCre IL-4Rα KO sham+sham, P < 0.05 by one-way ANOVA; †different from LysMCre IL-4Rα KO RV-A1B+RV-A2, P < 0.05 by one-way ANOVA.
Figure 7
Figure 7
LysMCre IL-4Rα KO attenuated epithelial IL-33 expression after heterologous RV infection. Six-day old immature wild-type and LysMCre IL-4Rα KO mice were inoculated with sham or RV-A1B on day 6 and sham or RV-A2 on day 13 of life. Lungs were harvested on day 14 (1 day post RV-A2 infection) and digested with liberase TM, collagenase XI, hyaluronidase 1a, and DNase I, and stained with anti-F4/80, anti-CD45, anti-EpCAM, and DAPI (for dead cells). (A) Cell suspensions were sorted for CD45+F4/80+ macrophages, CD45-EpCAM+ epithelial cells, and CD45-EpCAM- cells. (B) The cell pellet was collected for IL-33 or IL-25 mRNA expression by quantitative PCR. IL-33 and IL-25 mRNA expression of CD45+F4/80+ macrophages, CD45-EpCAM+ epithelial cells, and CD45-EpCAM- cells in wild-type mice. (N=6/group, lungs from two mice were combined for each measurement). Data shown are mean ± SD. (C) Epithelial derived IL-33 mRNA expression in CD45- EpCAM+ epithelial cells in wild-type and LysMCre IL-4Rα KO mice. Data shown are mean ± SD, *different from wild-type RV-A1B + sham, P < 0.05 by one-way ANOVA; †different from wild-type RV-A1B + + RV-A2, P < 0.05 by one-way ANOVA. (D) Lung IL-33 in wild-type and LysMCre IL-4Rα KO mice. .
See this image and copyright information in PMC

References

    1. Lemanske RF, Jr., Jackson DJ, Gangnon RE, Evans MD, Li Z, Shult PA, et al. . Rhinovirus illnesses during infancy predict subsequent childhood wheezing. J Allergy Clin Immunol (2005) 116(3):571–7. doi: 10.1016/j.jaci.2005.06.024 - DOI - PubMed
    1. Jackson DJ, Gangnon RE, Evans MD, Roberg KA, Anderson EL, Pappas TE, et al. . Wheezing rhinovirus illnesses in early life predict asthma development in high-risk children. Am J Respir Crit Care Med (2008) 178(7):667–72. doi: 10.1164/rccm.200802-309OC - DOI - PMC - PubMed
    1. Rubner FJ, Jackson DJ, Evans MD, Gangnon RE, Tisler CJ, Pappas TE, et al. . Early life rhinovirus wheezing, allergic sensitization, and asthma risk at adolescence. J Allergy Clin Immunol (2017) 139(2):501–7. doi: 10.1016/j.jaci.2016.03.049 - DOI - PMC - PubMed
    1. Kusel MM, de Klerk NH, Holt PG, Kebadze T, Johnston SL, Sly PD. Role of respiratory viruses in acute upper and lower respiratory tract illness in the first year of life: A birth cohort study. Pediatr Infect Dis J (2006) 25(8):680–6. doi: 10.1097/01.inf.0000226912.88900.a3 - DOI - PubMed
    1. Schneider D, Hong JY, Popova AP, Bowman ER, Linn MJ, McLean AM, et al. . Neonatal rhinovirus infection induces persistent mucous metaplasia and airways hyperresponsiveness. J Immunol (2012) 188(6):2894–904. doi: 10.4049/jimmunol.1101391 - DOI - PMC - PubMed

Publication types